Glenmark gets USFDA approval for Ranitidine tablets

US subsidiary of Glenmark Generics Ltd has received ANDA approval from the U.S. FDA for Ranitidine 150 mg and 300 mg tablets and will soon commence marketing and distribution of these products in the U.S. market.

The details can be read here.